Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleEditorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease.AuthorsCesarini, M.; Danese, S.AbstractA letter to the editor is presented in response to the article "Long-Term Safety and Efficacy of Certolizumab Pegol for Crohn's disease" by Sandborn et al. in the 2014 issue.SubjectsINFLAMMATORY bowel disease treatment; DRUG efficacyPublicationAlimentary Pharmacology & Therapeutics, 2014, Vol 40, Issue 10, p1243ISSN0269-2813Publication typeEditorialDOI10.1111/apt.12958